Company Overview

Company name: Sea Hunter Therapeutics
Description: Operator of a vertically integrated pharmaceutical and consumer packaged goods company in the cannabis industry. The company provides retail license holders with intellectual property, operating expertise, capital, a diverse range of products and differentiated brands. The company also develops and produces a broad line of branded cannabis products which it distributes wholesale.
Year founded:
Parent company: TILT Holdings
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
City: Cambridge
State: Massachusetts
Country: United States
Region: Americas

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Acquired/Merged (Operating Subsidiary)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company was acquired by TILT Holdings for an undisclosed amount on November 21, 2018. The acquisition resulted in the first fully-integrated, multi-national cannabis company focusing on delivering a broad array of industry solutions.
Number of active investors:
Profile last updated: 22-Nov-2018
Last known valuation:
Last known valuation date: